# Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.

> **NCT02651844** · NA · COMPLETED · sponsor: **Hospital Provincial Magdalena V. de Martínez** · enrollment: 20 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Mifepristone

## Key facts

- **NCT ID:** NCT02651844
- **Lead sponsor:** Hospital Provincial Magdalena V. de Martínez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651844, "Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02651844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*